Angiotensin Receptor Blockers

DRUG9 trials

Sponsors

Seiji Umemoto, M.D., Ph.D., Baylor Research Institute, UMC Utrecht, Sherief Abd-Elsalam, Medical Practice Prof D. Ivanov

Conditions

Aortic StenosisAortic Valve StenosisCOVID-19Cardiovascular DiseaseCardiovascular DiseasesCommunity-acquired Pneumonia, Influenza, COVID-19Coronary DiseaseCoronavirus Disease 2019

Phase 2

The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

CompletedNCT05232370

Unidad de Investigacion Medica en Enfermedades RenalesOxidative Stress

Start: 2022-01-01End: 2022-01-06Updated: 2022-02-09

Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

RecruitingNCT02735707

UMC UtrechtCommunity-acquired Pneumonia, Influenza, COVID-19

Start: 2016-04-11End: 2028-02-29Target: 20000Updated: 2024-07-12

Statins and ARBs on Rheumatoid Activity

RecruitingNCT03770702

Sherief Abd-ElsalamRheumatoid Arthritis

Start: 2018-10-01End: 2026-12-01Target: 45Updated: 2018-12-10

Phase 4

Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

CompletedNCT00135551

Seiji Umemoto, M.D., Ph.D.Cardiovascular Disease

Start: 2003-05-31End: 2010-11-30Updated: 2012-02-22

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

CompletedNCT04394117

The George InstituteCoronavirus Disease 2019, COVID-19

Start: 2020-06-19End: 2022-01-17Updated: 2022-03-17

Angiotensin Receptor Blockers in Aortic Stenosis

RecruitingNCT04913870

Institut universitaire de cardiologie et de pneumologie de Québec, University LavalAortic Stenosis, Aortic Valve Stenosis

Start: 2020-02-01End: 2027-02-28Target: 144Updated: 2024-12-20

Unknown Phase

Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation

CompletedNCT00224809

Baylor Research InstituteCardiovascular Diseases, Coronary Disease, Heart Diseases

Start: 2002-09-30End: 2007-05-31Target: 250Updated: 2014-02-19

ARB, ACEi, DRi Effects on COVID-19 Course Disease

CompletedNCT04364984

Medical Practice Prof D. IvanovCOVID-19, Hypertension

Start: 2020-04-01End: 2021-08-01Updated: 2023-03-21

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

Not yet recruitingNCT07262710

First Teaching Hospital of Tianjin University of Traditional Chinese MedicinePost-stroke Pneumonia

Start: 2025-12-01End: 2026-08-19Target: 13656Updated: 2025-12-04

Related Papers

Invasive Hemodynamic Exercise Response in Hemodynamically Significant Aortic Stenosis With Preserved Left Ventricular Ejection Fraction

Circulation Heart Failure2026-02-23

Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial

Thorax2025-05-139 citations

Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia

Intensive Care Medicine2025-04-0132 citations

A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial.

2023-12-068 citations

Simvastatin in Critically Ill Patients with Covid-19

New England Journal of Medicine2023-10-2559 citations

Intravenous Vitamin C for Patients Hospitalized With COVID-19

JAMA2023-10-2545 citations

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19

JAMA2023-04-1166 citations

The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors

The Journal of Infectious Diseases2023-03-274 citations

Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19

JAMA2023-03-2192 citations

The Impact of COVID-19 Research on the Development of Scalable Frameworks for Efficient Clinical Trials in Cardiovascular Medicine

Canadian Journal of Cardiology2023-03-153 citations

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.

2022-12-0128 citations

Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

BMJ2022-11-1639 citations

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.

2022-09-2211 citations

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

Trials2022-04-273 citations

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

JAMA2022-03-22144 citations

Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial

BMJ2022-01-0779 citations

Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID‐19: Insights from the HOPE COVID‐19 Registry

International Journal of Clinical Practice2022-01-015 citations

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19

JAMA2021-10-05208 citations

Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial.

2021-08-287 citations

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Bristol Research (University of Bristol)2021-08-26586 citations

10 more papers not shown